HEMOGLOBIN F & A2 CONTROL (BETA-THALASSAEMIA CONTROL)— 510(k) K011389

Substantially Equivalent

Canterbury Health Laboratories

FDA 510(k) clearance K011389 for HEMOGLOBIN F & A2 CONTROL (BETA-THALASSAEMIA CONTROL), Substantially Equivalent on 2001-06-21. Applicant: Canterbury Health Laboratories.

Clearance details

Applicant: Canterbury Health Laboratories
Product code: Code JCM
Advisory panel: Hematology
Date received: 2001-05-07
Decision date: 2001-06-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Christchurch, Canterbury, NZ

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.